Retatrutide enhances insulin secretion, suppresses glucagon, slows gastric emptying, and creates significant caloric deficit through appetite suppression
severe hepatic impairment (cirrhosis, hepatic failure, hepatitis B or C-positive serology, alanine aminotransferase or aspartate aminotransferase 2.5 times the upper limit of normal)
TSH, free T4, and thyroid ultrasound at baseline and at 6-month intervals is a reasonable monitoring schedule
Window End of cycle What's commonly tracked Repeat fasting glucose, fasting insulin, waist circumference What it tells you Comparison vs
GLP-1(7-36) can suppress glucagon secretion in cells by increasing cAMP levels, activating PKA and EPAC, leading to a decrease in intracellular calcium concentration and reduced glucagon release